Related Experiment Video
Updated: May 10, 2025
Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts
Published on: August 7, 2018
In Vitro Study on the Antitumor Bioactivity of Anderson-Type Polyoxometalates
Chenguang Yao1, Ting Tan1, Jiangning Yan1
1Hubei Provincial Key Laboratory of Industrial Microbiology, Key Laboratory of Fermentation Engineering (Ministry of Education), Sino-German Biomedical Center, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, Hubei, PR China.
Objective:
To develop new Anderson-type polyoxometalates (POMs) with high efficiency and low cytotoxicity, and investigate the effects and mechanisms against lung (A549), cervical (Hela), and breast cancer (MCF7) cell lines.
Methods:
Cytotoxicity assessments on Hela, A549, and MCF-7 tumor cells were tested by MTT assay. Antitumor activities of B1 (vanadium-centered, methyl-modified) and B7 (vanadium-centered, hydroxylmodified) were detected by apoptosis, scratch, and colony formation assay. The antitumor molecular mechanisms were explored by Western blotting.
Results:
This study synthesized and evaluated twelve Anderson-type compounds which were centered with vanadium, chromium, iron, cobalt, nickel, and copper heteroatoms, modified with methyl and hydroxyl at the side chains. Cytotoxicity assessments revealed that compounds B1 and B7 exhibited superior efficacy, with IC50 values of approximately 7 μmol/L of three cell lines. B1 and B7 inhibited proliferation and migration in these cell lines and induced apoptosis in MCF7 and A549 cells. Mechanistic investigations indicated that B1 induces apoptosis in MCF7 cells by inhibiting the AKT signaling pathway and downregulating the expression of apoptosis-related proteins Bcl-2 and Caspase-9.
Conclusion:
Novel Anderson-type POMs B1 (vanadium-centered, methyl-modified) and B7 (vanadiumcentered, hydroxyl-modified) exhibited superior efficacy against tumor cells and induced apoptosis via PI3K/ AKT pathway, which provides new theoretical avenues for developing POM-mediated antitumor chemotherapeutic medications.
Insights
New Anderson-type polyoxometalates (POMs), B1 and B7, show high efficacy against lung, cervical, and breast cancer cells. These POMs induce apoptosis and inhibit cancer cell proliferation and migration.
Area of Science:
- Inorganic Chemistry
- Materials Science
- Medicinal Chemistry
Background:
- Polyoxometalates (POMs) are versatile inorganic clusters with potential therapeutic applications.
- Developing novel POMs with enhanced anticancer activity and reduced toxicity is a key research area.
- Anderson-type POMs offer a unique structural framework for modification and functionalization.
Purpose of the Study:
- To synthesize and characterize novel Anderson-type polyoxometalates (POMs).
- To evaluate the in vitro anticancer efficacy of these POMs against lung (A549), cervical (Hela), and breast (MCF7) cancer cell lines.
- To elucidate the molecular mechanisms underlying their antitumor activity.
Main Methods:
- Synthesis and characterization of twelve Anderson-type POMs with various heteroatoms and side-chain modifications.
- Cytotoxicity was assessed using MTT assays.
- Antitumor effects were evaluated through apoptosis, scratch, and colony formation assays.
- Western blotting was employed to investigate molecular mechanisms.
Main Results:
- Compounds B1 (vanadium-centered, methyl-modified) and B7 (vanadium-centered, hydroxyl-modified) demonstrated significant efficacy with IC50 values around 7 μmol/L across tested cell lines.
- B1 and B7 effectively inhibited cancer cell proliferation and migration.
- Apoptosis was induced in MCF7 and A549 cells by B1 and B7.
- Mechanistic studies revealed that B1 induces apoptosis in MCF7 cells by inhibiting the AKT signaling pathway and downregulating Bcl-2 and Caspase-9 expression.
Conclusions:
- Novel Anderson-type POMs B1 and B7 exhibit potent anticancer activity against multiple human cancer cell lines.
- These POMs induce apoptosis through the PI3K/AKT pathway, offering a promising therapeutic strategy.
- The findings provide a foundation for developing POM-based chemotherapeutic agents.
